Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares
08 Oct 2026
PR Newswire Association LLC.
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
06 Oct 2026
PR Newswire Association LLC.
ADAMA Launches Botanical Fungicide Actavan® in Australia and New Zealand
01 Oct 2026
PR Newswire Association LLC.
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
30 Sep 2026
PR Newswire Association LLC.
PlantArcBio's Yield Increasing and Drought-Tolerance Genes Deliver Stronger Yields in First Open-Field Corn Trial
24 Sep 2026
PR Newswire Association LLC.
LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads
24 Sep 2026
PR Newswire Association LLC.
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement
21 Sep 2026
PR Newswire Association LLC.
Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV Congress
16 Sep 2026
PR Newswire Association LLC.
FDA Advisory Panel Backs BPC-157 for 503A Bulks List in 8-6-1 Vote, Promise Analysis Finds
08 Sep 2026
PR Newswire Association LLC.
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION
04 Sep 2026
PR Newswire Association LLC.
Singapore is the first ASEAN country to provide government subsidy for eligible patients receiving vutrisiran for transthyretin amyloidosis
01 Sep 2026
PR Newswire Association LLC.
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS
31 Aug 2026
PR Newswire Association LLC.
BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update
31 Aug 2026
PR Newswire Association LLC.
BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
28 Aug 2026
GlobeNewswire
Entera Announces Second Quarter 2026 Financial Results and Business Updates
07 Aug 2026
GlobeNewswire
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
07 Aug 2026
GlobeNewswire
Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
06 Aug 2026
GlobeNewswire
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
05 Aug 2026
GlobeNewswire
SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
05 Aug 2026
GlobeNewswire
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
05 Aug 2026
GlobeNewswire
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
05 Aug 2026
GlobeNewswire
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
04 Aug 2026
GlobeNewswire
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
04 Aug 2026
GlobeNewswire
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
03 Aug 2026
GlobeNewswire
J-Star Holding Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
31 Jul 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
31 Jul 2026
Upcoming Events All Events
- October 2026
- Yokohama: BioJapan
- Queensland: AusBiotech Invest
- Queensland: AusBiotech International Conference